Cardiac Troponin Market, By Product Type (High-Sensitivity Cardiac Troponin Tests, Conventional Cardiac Troponin Tests, and Point-of-Care Troponin Tests), By Test Type, By End-user, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4188
|
Published Date
July 2025
|
Pages
392
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Cardiac Troponin Market size was valued at US$ 3,345.12 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.
The cardiac troponin market centers on the development and sale of diagnostic tests that measure troponin levels in the blood—crucial biomarkers for detecting heart muscle damage, especially in cases of myocardial infarction (heart attack). Cardiac troponins, specifically troponin I (cTnI) and troponin T (cTnT), are proteins released into the bloodstream when the heart is injured, making them highly sensitive and specific indicators of cardiac events. Market growth is driven by the rising global prevalence of cardiovascular diseases (CVDs), increasing demand for early and accurate diagnosis, and ongoing advancements in high-sensitivity troponin assays (hs-cTn tests). These advanced tests enable the rapid detection of heart attacks, which is critical for timely intervention and improved patient outcomes. Hospitals, diagnostic laboratories, and emergency care centers are the primary end-users of cardiac troponin tests. Major industry players—including Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Beckman Coulter—compete through technological innovation, product differentiation, and the pursuit of regulatory approvals.
The market is further propelled by aging populations, sedentary lifestyles, and growing public awareness around cardiac health. However, it faces challenges such as the high cost of advanced diagnostic equipment and stringent regulatory frameworks that can delay product approvals and market entry. Overall, the cardiac troponin market is poised for steady growth, underpinned by the increasing need for accurate and timely cardiac diagnostics in both developed and emerging healthcare systems.
Cardiac Troponin Market- Market Dynamics
Increasing Demand for High-Sensitivity Troponin Tests in Emergency Diagnostics
A key driver of the cardiac troponin market is the rising demand for high-sensitivity troponin (hs-cTn) assays. These advanced tests can detect even minute levels of troponin in the blood, allowing for earlier and more accurate diagnosis of heart attacks compared to conventional methods. Emergency departments heavily rely on hs-cTn tests to rapidly rule in or rule out myocardial infarction, improving patient triage and reducing unnecessary hospital admissions. With the global rise in cardiovascular diseases (CVDs), rapid and precise diagnosis has become critical for better patient outcomes. High-sensitivity assays enable faster clinical decision-making, especially in cases of non-ST-elevation myocardial infarction (NSTEMI), where symptoms may be subtle or ambiguous. Furthermore, regulatory approvals and clinical guidelines recommending the use of hs-cTn tests are driving increased adoption worldwide.
Governments and health organizations globally are supporting the use of advanced cardiac diagnostics to reduce CVD mortality. For example, the U.S. Food and Drug Administration (FDA) has approved multiple hs-cTn assays, while the European Society of Cardiology (ESC) has incorporated hs-cTn testing into its acute coronary syndrome management guidelines. Additionally, initiatives like the World Health Organization’s Global Hearts Initiative promote early detection and management of cardiovascular diseases, further boosting demand for sensitive diagnostic tools. Hospitals and diagnostic laboratories are increasingly integrating these assays to enhance efficiency in acute care settings. Consequently, leading diagnostic companies are investing heavily in the development of next-generation hs-cTn tests, fueling innovation and competition within the cardiac troponin market. This trend is expected to persist as healthcare systems worldwide prioritize faster, more reliable cardiac diagnostics.
Cardiac Troponin Market- Key Insights
- According to analysis from our research analyst, the global cardiac troponin market is projected to grow at a compound annual growth rate (CAGR) of approximately 8.5% during the forecast period from 2025 to 2032.
- In terms of product type, High-Sensitivity Cardiac Troponin (hs-cTn) tests are expected to hold the largest market share in 2024.
- By test type, Troponin I tests emerged as the leading segment in 2024.
- Regarding end-users, hospitals and emergency departments were the dominant adopters in 2024.
- Regionally, North America was the top revenue generator for the cardiac troponin market in 2024.
Cardiac Troponin Market- Segmentation Analysis:
The Global Cardiac Troponin Market is segmented on the basis of Product Type, Test Type, End-user, and Region.
The cardiac troponin market is segmented based on product type into High-Sensitivity Cardiac Troponin (hs-cTn) Tests, Conventional Cardiac Troponin Tests, and Point-of-Care Troponin Tests. The High-Sensitivity Cardiac Troponin Tests segment dominates this market due to its superior clinical utility in the early and accurate diagnosis of myocardial infarction (heart attack). These advanced assays can detect much lower levels of troponin in the blood compared to conventional tests, allowing physicians to identify cardiac damage within 1 to 2 hours of symptom onset. This rapid detection is crucial in emergency settings, where timely intervention significantly improves patient outcomes and reduces mortality rates. The global burden of cardiovascular diseases remains a leading cause of death, with the World Health Organization (WHO) reporting approximately 17.9 million deaths annually, accounting for 32% of all global deaths. In response, many governments worldwide, including the United States, the European Union, and China, have integrated hs-cTn testing into national guidelines for acute coronary syndrome management, investing in infrastructure to ensure rapid and accurate diagnostics in emergency care settings. Leading diagnostic companies such as Roche, Abbott, and Siemens continue to drive innovation and market expansion through significant investments in high-sensitivity assays, further solidifying the dominance of this segment.
The market is also classified by test type into Troponin I (cTnI) and Troponin T (cTnT), with Troponin I tests holding the largest market share globally. Troponin I assays are favored because of their superior cardiac specificity—troponin I is exclusively expressed in cardiac muscle, whereas troponin T may show minor cross-reactivity with skeletal muscle. This specificity reduces diagnostic errors, making cTnI tests highly reliable in clinical practice. Major industry players such as Abbott Laboratories and Beckman Coulter have heavily invested in cTnI assay development, with Abbott’s High-Sensitivity Troponin I test leading in key markets like the U.S. and Europe. The widespread adoption of cTnI assays is reflected in clinical guidelines and standardized protocols for acute coronary syndromes, endorsed by organizations such as the American College of Cardiology (ACC) and the European Society of Cardiology (ESC). Unlike cTnT, which is largely controlled by Roche’s proprietary Elecsys platform, cTnI assays are produced by multiple manufacturers, fostering competition and driving improvements in analytical performance. This is particularly beneficial in patient populations with comorbidities such as renal disease, where cTnI tests demonstrate enhanced accuracy. Government healthcare programs in countries with high cardiovascular disease burdens have increasingly recommended the use of cTnI tests to improve diagnostic precision and patient care, thereby reinforcing its dominant position as the preferred biomarker in modern cardiac diagnostics.
Cardiac Troponin Market- Competitive Landscape:
The competitive landscape of the cardiac troponin market is marked by intense rivalry among leading global diagnostics companies, fueled by continuous innovation, regulatory approvals, and strategic partnerships. Market leaders such as Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers dominate by offering advanced high-sensitivity troponin (hs-cTn) assays and leveraging extensive end-user networks. These companies compete primarily on assay accuracy, speed, and clinical utility, with Roche’s Elecsys Troponin T and Abbott’s Architect STAT hs-Troponin-I among the most widely adopted tests. Mid-sized firms like QuidelOrtho, bioMérieux, and Beckman Coulter focus on niche areas, including point-of-care testing (POCT) and automated laboratory systems. Meanwhile, emerging players such as Randox Laboratories and Getein Biotech target cost-sensitive markets by providing more affordable diagnostic alternatives. The market is also being reshaped by mergers and acquisitions—such as Quidel’s merger with Ortho Clinical Diagnostics—which enhance technological capabilities and expand product portfolios.
Recent Developments:
- In June 2024, Abbott Laboratories received FDA clearance for its next-generation High-Sensitivity Troponin-I assay on the Alinity ci-series analyzers, enabling faster and more accurate myocardial infarction (MI) diagnosis in U.S. hospitals.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CARDIAC TROPONIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Roche Diagnostics
- Siemens Healthineers
- Beckman Coulter
- bioMérieux
- Thermo Fisher Scientific
- QuidelOrtho
- Becton Dickinson
- Sysmex Corporation
- PerkinElmer
- Bio-Rad Laboratories
- Fujirebio
- DiaSorin
- Randox Laboratories
- Tosoh Corporation
- Ortho Clinical Diagnostics
- Merck KGaA
- ELITechGroup
- Getein Biotech
- Response Biomedical
GLOBAL CARDIAC TROPONIN MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- High-Sensitivity Cardiac Troponin Tests
- Conventional Cardiac Troponin Tests
- Point-of-Care Troponin Tests
GLOBAL CARDIAC TROPONIN MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Troponin I
- Troponin T
GLOBAL CARDIAC TROPONIN MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Emergency Departments
- Diagnostic & Clinical Laboratories
- Ambulatory Surgical Centers
- Others
GLOBAL CARDIAC TROPONIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Cardiac Troponin Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Cardiac Troponin Market Snippet by Product Type
2.1.2. Cardiac Troponin Market Snippet by Test Type
2.1.3. Cardiac Troponin Market Snippet by End-user
2.1.4. Cardiac Troponin Market Snippet by Country
2.1.5. Cardiac Troponin Market Snippet by Region
2.2. Competitive Insights
3. Cardiac Troponin Key Market Trends
3.1. Cardiac Troponin Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Cardiac Troponin Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Cardiac Troponin Market Opportunities
3.4. Cardiac Troponin Market Future Trends
4. Cardiac Troponin Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Cardiac Troponin Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Cardiac Troponin Market Landscape
6.1. Cardiac Troponin Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Cardiac Troponin Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. High-Sensitivity Cardiac Troponin Tests
7.1.3. Conventional Cardiac Troponin Tests
7.1.4. Point-of-Care Troponin Tests
8. Cardiac Troponin Market – By Test Type
8.1. Overview
8.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
8.1.2. Troponin I
8.1.3. Troponin T
9. Cardiac Troponin Market – By End-user
9.1. Overview
9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
9.1.2. Hospitals & Emergency Departments
9.1.3. Diagnostic & Clinical Laboratories
9.1.4. Ambulatory Surgical Centers
9.1.5. Others
10. Cardiac Troponin Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Cardiac Troponin Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Cardiac Troponin Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Cardiac Troponin Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Cardiac Troponin Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Cardiac Troponin Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Cardiac Troponin Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.2. Roche Diagnostics
11.2.3. Siemens Healthineers
11.2.4. Beckman Coulter
11.2.5. bioMérieux
11.2.6. Thermo Fisher Scientific
11.2.7. QuidelOrtho
11.2.8. Becton Dickinson
11.2.9. Sysmex Corporation
11.2.10. PerkinElmer
11.2.11. Bio-Rad Laboratories
11.2.12. Fujirebio
11.2.13. DiaSorin
11.2.14. Randox Laboratories
11.2.15. Tosoh Corporation
11.2.16. Ortho Clinical Diagnostics
11.2.17. Merck KGaA
11.2.18. ELITechGroup
11.2.19. Getein Biotech
11.2.20. Response Biomedical
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
